The study that led the FDA to approve an AI system for diagnosing diabetic retinopathy came out today, revealing how one of the leading causes of blindness can be detected in a primary care physician’s office.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,